Stay updated on Itacitinib Combinations in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Itacitinib Combinations in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Itacitinib Combinations in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe web page has updated its facility name and location details, while also adding new drug names such as parsaclisib, epacadostat, INCB039110, and itacitinib. The revision number has changed from v2.16.12 to v3.0.0.SummaryDifference1%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
- Check36 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.3%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to Itacitinib Combinations in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Itacitinib Combinations in Advanced Solid Tumors Clinical Trial page.